Inhibiting C1 either through genetic ablation (C1qa) or pharmacologically (C1 esterase inhibitor) prevents RGC dendritic and synaptic changes during glaucoma in both DBA/2 J mice and a rat bead model of ocular hypertension [6, 9]. This evidence concerns the gene C1S and glaucoma.